A. Baker

lncRNA/MicroRNA interactions in the vasculature

M. Ballantyne, RA McDonald, A. Baker, 2016, Clinical pharmacology and therapeutics.

Transforming growth factor-beta signaling via ALK1 and ALK5 regulates distinct functional pathways in vein graft intimal hyperplasia

A. Baker, J. McClure, M. McBride, 2019, bioRxiv.

Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins

A. Baker, A. Newby, G. Angelini, 1998, Gene Therapy.

A pig model of vein graft disease applications for potential gene therapies.

G. Angelini, A. Baker, S. George, 2001, Methods in molecular medicine.

Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.

A. Baker, S. George, A. Newby, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Prevention of vein graft failure: potential applications for gene therapy.

G. Angelini, A. Baker, S. George, 1997, Cardiovascular research.

Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3

A. Baker, A. Baker, G. Murphy, 1999, British Journal of Cancer.

Nuclear factor kappaB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fibroblasts.

A. Baker, A. Baker, A. Newby, 1999, Biochemical and biophysical research communications.